Updated 12 sec ago · auto-refreshing
Trending claims
The fastest-moving factual assertions across the open web, ranked by velocity and weighted by credibility.
The 2015 book 'Rising Strong' by social scientist Dr. Brené Brown explores how people recover from failures.
The book 'The Inner Game of Tennis' by W. Timothy Gallwey, first published in 1974, is about overcoming self-doubt and overthinking.
Dr. Brené Brown's book 'Rising Strong' outlines a three-part process for dealing with failure: reckoning, rumbling, and revolution.
In her book 'Right Kind of Wrong', Dr. Amy Edmonson distinguishes between basic, complex, and intelligent failures.
Dr. Kristin Neff's book 'Self-Compassion', published in 2011, presents self-compassion as an alternative to self-esteem and includes exercises.
Amanda Cassil is a clinical psychologist in Pasadena, California.
Sandhya Krishnan is a postdoctoral research fellow at the University of Arkansas at Little Rock who has studied failure.
The book 'Right Kind of Wrong' was published in 2023.
Ashley Chin is a clinical psychologist in Gainesville, Florida.
Paul Losoff is a clinical psychologist in Northbrook, Illinois.
Dr. Lucas stated that subtle shifts like changes in blood glucose or unexplained weight loss can be clues to pancreatic disease two to three years before diagnosis.
The author's brother, Ron, is 71 years old.
The author's brother, Bill, had his funeral about two weeks after the author visited him.
Dr. Anna Berkenblit of the Pancreatic Cancer Action Network stated that two recent developments have the potential to be game changers for pancreatic cancer.
The author's brother, Darrell, died about a week after the author visited him.
Dr. Lucas stated that in most cases, pancreatic cancer does not manifest before age 50, so testing before then is not usually recommended.
Dr. Anna Berkenblit is the chief scientific and medical officer of the Pancreatic Cancer Action Network.
The drug daraxonrasib, recently approved by the FDA, doubled life expectancy to over 13 months for certain metastatic pancreatic cancer patients in a clinical trial, compared to under 7 months for those on chemotherapy.
The author's brother Bill, who died at 74, had served in the Navy for 30 years.
A new treatment for high-risk pancreatic cancer patients with removed tumors involves a vaccine using mRNA technology.